Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global knee & hip disorders market size was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.5 billion by 2031, growing at a CAGR of 6.1% during the forecast period. This growth is driven by rising geriatric populations, increasing osteoarthritis prevalence, and technological advancements in joint replacement procedures.
Knee and hip disorders encompass a range of conditions affecting these critical weight-bearing joints, including osteoarthritis, rheumatoid arthritis, fractures, and congenital abnormalities. The knee joint connects the femur to the tibia, while the hip functions as a ball-and-socket synovial joint. Treatments include both surgical interventions like total joint replacements and non-surgical approaches such as physical therapy and pain management.
The market expansion is further supported by increasing obesity rates and growing demand for minimally invasive surgical techniques. North America currently dominates market share due to its advanced healthcare infrastructure and high procedure volumes, while Asia-Pacific is emerging as the fastest-growing region due to improving healthcare access and rising medical tourism for orthopedic procedures.
Aging Population and Rising Prevalence of Osteoarthritis
The global knee & hip disorders market is primarily driven by the increasing geriatric population, with over 20% of people aged 60+ experiencing osteoarthritis symptoms. Projections indicate this demographic will double by 2050, significantly expanding the patient pool.
Advancements in Surgical Techniques
Minimally invasive procedures and robotic-assisted surgeries are gaining traction, with adoption rates increasing by 15% annually. These technologies reduce recovery times and improve outcomes, making joint replacement more appealing to patients.
Growing awareness and early diagnosis campaigns have increased treatment-seeking behavior by 28% over the past decade
Healthcare systems worldwide are prioritizing musculoskeletal health, with many countries implementing national arthritis programs that include subsidized joint replacement procedures.
MARKET CHALLENGES
High Cost of Advanced Treatments
Premium implants and robotic surgery systems can increase procedure costs by 40-60% compared to conventional methods, creating accessibility issues in cost-sensitive markets.
Other Challenges
Reimbursement Limitations
Variations in insurance coverage and government reimbursement policies create uneven access to advanced treatments across different regions.
Surgical Complications
Despite improvements, revision surgeries still account for approximately 8-10% of total knee replacements, posing clinical and economic challenges.
COVID-19 Pandemic Aftereffects
Elective procedure backlogs and postponed surgeries during the pandemic continue to impact market recovery, with approximately 30% of delayed cases still awaiting rescheduling in most healthcare systems.
Patient Reluctance Towards Surgery
Non-surgical alternatives continue to capture 35-40% of the addressable market, with many patients opting for pain management approaches despite limited long-term efficacy.
Emerging Markets Growth
Developing nations with improving healthcare infrastructure represent a $12 billion opportunity, with projected CAGR of 9.2% through 2030 in Asia-Pacific and Latin American markets.
Personalized Implant Technology
3D-printed and patient-specific implants are showing 25% better outcomes in clinical trials, with adoption expected to reach 45% of premium segment procedures by 2028.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Knee Disorders & Treatment dominates due to higher prevalence of conditions like tendinitis and meniscus tears, coupled with technological advancements in minimally invasive procedures. Hip Disorders and Treatments show steady growth driven by rising arthritis cases and an aging population requiring joint replacements, though procedural complexity remains a key consideration. |
| By Application |
|
Hospitals lead as the primary treatment centers due to their comprehensive facilities for complex joint surgeries and postoperative care. Ambulatory Surgical Centers are gaining traction for less complicated procedures, benefiting from shorter recovery times and cost-efficiency. Diagnostic Centers play a crucial role in early detection and conservative treatment approaches. |
| By End User |
|
Geriatric Patients represent the largest segment due to age-related degenerative joint conditions and osteoporosis prevalence. Adult Patients show significant demand from sports injuries and occupational hazards, while Pediatric cases are concentrated on congenital disorders requiring specialized implants and surgical approaches. |
| By Treatment Approach |
|
Surgical Interventions remain the cornerstone for advanced joint degeneration, with innovations like robotic-assisted procedures gaining prominence. Non-Surgical Therapies maintain relevance for early-stage disorders, featuring pain management injections and physical therapy protocols. Rehabilitation services are becoming increasingly integrated into treatment pathways to optimize long-term mobility outcomes. |
| By Technology |
|
Robotic-Assisted Surgery is emerging as a game-changer, offering superior precision in joint alignment and implant placement. Traditional Implants continue to dominate current practice due to cost-effectiveness and surgeon familiarity. Patient-specific instrumentation demonstrates promising growth, particularly for complex anatomical variations, enhancing surgical outcomes through customized solutions. |
Global Knee & Hip Disorders Market Dominated by Medical Device Giants
The knee and hip disorders market is characterized by the dominance of large multinational medical device corporations with extensive R&D capabilities and global distribution networks. Johnson & Johnson leads the market through its DePuy Synthes subsidiary, offering comprehensive orthopedics solutions. Zimmer Biomet and Stryker follow closely, with both companies investing heavily in innovative implant technologies and minimally invasive surgical techniques.
Several mid-sized players maintain strong positions in niche segments, particularly in emerging markets. Smith & Nephew has carved out significant market share with its advanced bearing technologies, while regional players like Valletta Orthopaedics specialize in customized solutions. The industry continues to see technological advancements in materials (ceramic and highly cross-linked polyethylene) and robotic-assisted surgical systems.
List of Key Knee & Hip Disorders Companies ProfiledB. Braun Melsungen AG
Corin Group
Exactech, Inc.
MicroPort Scientific Corporation
Lima Corporate
Valletta Orthopaedics Ltd.
Medacta International
Aesculap Implant Systems
The global Knee & Hip Disorders market was valued at $X million in 2024 and is projected to reach US$ Y million by 2031, growing at a CAGR of Z% during the forecast period. This growth is primarily fueled by the increasing geriatric population worldwide who are more susceptible to joint disorders. The U.S. market remains the largest contributor due to its advanced healthcare infrastructure and higher prevalence of obesity-related joint problems.
Other TrendsTechnological Advancements in Implant Materials
Recent innovations include improved polyethylene materials and 3D-printed custom implants that offer better durability and fit. Major players like Zimmer Biomet and Stryker are investing heavily in robotic-assisted surgical systems, which improve surgical precision and patient outcomes.
Shift Towards Outpatient Surgical CentersThere's a growing preference for ambulatory surgical centers over traditional hospitals for knee and hip procedures, reducing costs and hospital stay durations. The segment is projected to grow at 6.8% CAGR through 2031. Minimally invasive techniques are driving this trend, with faster recovery times appealing to both patients and insurers.
Regional Market Developments
Asia-Pacific is emerging as the fastest-growing region with improving healthcare infrastructure, particularly in China and India. Government initiatives for affordable joint replacement surgeries and rising awareness are contributing to this growth. Europe maintains steady growth due to its expanding elderly population and comprehensive healthcare coverage.
Increased Focus on Revision SurgeriesWith the aging population of patients who received implants 10-15 years ago, revision surgeries are becoming a significant market segment. Manufacturers are developing specialized implants and instrumentation for these complex procedures, which now account for nearly 18% of total joint replacement surgeries.
Regional Analysis: Knee & Hip Disorders MarketEurope
Europe represents the second-largest market for knee & hip disorders, characterized by universal healthcare systems and standardized treatment protocols. The region shows particular strength in outpatient joint replacement programs and rehabilitation services. Germany and France lead in procedure volumes, while Nordic countries excel in post-operative recovery outcomes. Stringent EU medical device regulations create high barriers to entry but ensure product quality. Market growth faces some constraints from healthcare budget pressures and increasing preference for conservative treatment approaches where clinically appropriate.
Asia-Pacific
The Asia-Pacific region demonstrates the fastest growth in knee & hip disorder treatments, driven by improving healthcare access and rising disposable incomes. Japan and South Korea have mature markets with high technology adoption, while China and India present substantial untapped potential. Cultural factors influence treatment preferences, with some markets showing reluctance toward elective joint surgery. Local manufacturers are gaining share through cost-effective solutions, though quality perceptions still favor multinational offerings in premium hospital segments.
Latin America
Latin America's market growth is constrained by economic volatility but benefits from increasing medical tourism and expanding private healthcare infrastructure. Brazil and Mexico dominate regional demand, with Argentina showing promising growth in urban centers. Market challenges include limited reimbursement coverage and uneven distribution of specialized orthopedic care outside major cities. Local production of implants helps address cost concerns, though premium segments remain import-dependent.
Middle East & Africa
This region presents significant disparities, with Gulf Cooperation Council countries showing advanced medical capabilities and high procedure rates, while much of Africa lacks basic orthopedic services. Medical tourism hubs in the UAE, Turkey, and South Africa attract patients from across the region. Market growth faces challenges from limited local manufacturing and reliance on international aid programs for basic medical equipment in lower-income countries.
This market research report offers a comprehensive analysis of global and regional markets for the forecast period 20242031. It provides accurate market intelligence derived from primary and secondary research methodologies.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and CAGR projections
Segmentation Analysis
By disorder type (knee vs hip)
By treatment approach
By end-user healthcare setting
By technology type
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level analysis for key markets
Competitive Landscape
Company profiles and market share analysis
Mergers, acquisitions, and strategic collaborations
Product portfolio and pricing analysis
Technology & Innovation
Emerging surgical techniques and implant technologies
Robotic-assisted surgery and 3D printing applications
Smart implants and IoT integration
Market Dynamics
Key factors driving market growth
Regulatory challenges and reimbursement pressures
Supply chain considerations
Opportunities & Recommendations
Emerging market potential
Investment priorities for stakeholders
Strategic growth recommendations
Stakeholder Insights
This report is designed to support decision-making for various industry stakeholders including:
Medical device manufacturers
Healthcare providers and hospital networks
Orthopedic surgeons and specialists
Investors and venture capital firms
Regulatory bodies and policy makers
-> Global knee & hip disorders market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.5 billion by 2031, growing at a CAGR of 6.1% during the forecast period.
Which key companies operate in Global Knee & Hip Disorders Market?
-> Key players include Johnson & Johnson, Zimmer Biomet, Stryker, Smith and Nephew, and DePuy Synthes, among others.
-> Key growth drivers include aging populations, rising osteoarthritis prevalence, and technological advancements in joint replacement procedures.
-> North America currently leads market share, while Asia-Pacific is emerging as the fastest-growing region.
-> Emerging trends include robotic-assisted surgeries, personalized implants, and growing demand for minimally invasive procedures.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates